Pharma Growth Strategies LLC Company Profile

18:48 EDT 22nd June 2018 | BioPortfolio

PGS is a small firm. We believe that allows us to maximize your return on investment. Here's why.• Work with top guns
You won't pay our people to learn your business. We have no junior partners. When you deal with the "top gun" you know you will have access to the key decision maker and action-taker. If we must subcontract, it will be with seasoned professionals.
• Genuine partnership
We need you as much as you need us. Each of our clients is very important to us. When you engage us, it is a win/win collaboration.
You Work with Big 5 Firms - Great!
A partnership of PGS with a large firm can be an ideal solution for many clients. Consider this, when you retain a Big 5 firm you are not assured of their best people being involved with all facets of the project, and you can't expect a Big 5 firm to know your business inside and out from start to finish. The truth is that the Big 5 business model simply doens't allow their best, most knowledgable industry specialists to be committed to a single client for very long. Ours does. Ask us about how to bring the best of both worlds to your most important strategic projects.


13 Summit Square Center, #132
United States of America


Phone: 1 215 860 3336

News Articles [1431 Associated News Articles listed on BioPortfolio]

EUSA Pharma: Strategies of a Speciality Company

In this exclusive interview, Fintan Walton talks to Bryan Morton, Founder and CEO of EUSA Pharma. Bryan begins by discussing the establishment of EUSA Pharma, and how its formation was motivated by th...

Bayer Schering Pharma: Michael Yeomans on Growth in Pharma and New Deals

In this episode of PharmaTelevision News Review, Fintan Walton talks with Michael Yeomans, VP Business Development & Licensing at Bayer Schering Pharma*. Filmed at BioChicago 2010 in Chicago, USA, the...

Leading Pharma gets $40 million infusion for growth

David SalazarLeading Pharma said that its growth capital, led by Signet Healthcare Partners and Crestline Investors, will be used to expand the Fairfield, N.J.-based company’s pipeline and ...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

TVM Capital: Investment Strategies, Relationships with Big Pharma and Biotech Financing

In this episode of PharmaTelevision News Review, Fintan Walton talks with Dr Axel Polack, General Partner at TVM Capital. Filmed at BioBusiness 2010 in London, England, they discuss: • TVM’s inves...

Pharma Marketing Strategies: Why Teams Turn to Vendors When Engaging in Digital Activities

The post Pharma Marketing Strategies: Why Teams Turn to Vendors When Engaging in Digital Activities appeared first on Competitive Intelligence Performance Metrics | Cutting Edge Information.

PCI Pharma Services is heading to Biotech Outsourcing Strategies CMC

PCI Pharma Services will exhibit at the upcoming event taking place 19–20 June at the Congress Centre, Basel

Acceleron Pharma Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 19022018] Prices from USD $350

Acceleron Pharma Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Acceleron Pharma Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment...

Drugs and Medications [271 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [2446 Associated PubMed Articles listed on BioPortfolio]

Opportunities in biotechnology.

Strategies for biotechnology must take account of opportunities for research, innovation and business growth. At a regional level, public-private collaborations provide potential for such growth and t...

Fungal Spoilage in Food Processing.

Food processing, packaging, and formulation strategies are often specifically designed to inhibit or control microbial growth to prevent spoilage. Some of the most restrictive strategies rely solely o...

A guide to manufacturing CAR T cell therapies.

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

Growth patterns of Palestinian children from birth to 24 months.

Growth faltering in early life can adversely affect health in later childhood and adulthood. Growth monitoring of children can provide evidence to help formulate effective strategies to address growth...

Moving pharma contracting into the era of accountability.

Clinical Trials [4512 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [2031 Associated Companies listed on BioPortfolio]


Exmoor pharma concept is a small friendly and innovate consultancy,specialising in biopharma and secondary pharma and helping our clients to develop their facilities and manufacturing strategies.This ...

Pharma Active

Pharmaceutical industry has become one of the fastest growing industry. With growth comes the need for experienced professionals and various resources such as clinical trial centres, toxicology centre...

The Cambridge Group

The Cambridge Group ( is a strategy consulting firm focused on the development of growth strategies for Fortune 500 companies. For over 30 years, The Cambridge Gr...

Scientia Advisors, LLC

Scientia Advisors, based in Boston and San Francisco, is a growth strategy firm for the healthcare industry. Scientia works closely with senior management to develop corpor...

Indus Pharma

Indus Pharma is one of the fastest growing ISO 9001:2008 certified pharmaceutical manufacturers in Pakistan and is a one of the top Pakistani pharmaceutical exporter. Indus Pharma...

More Information about "Pharma Growth Strategies LLC" on BioPortfolio

We have published hundreds of Pharma Growth Strategies LLC news stories on BioPortfolio along with dozens of Pharma Growth Strategies LLC Clinical Trials and PubMed Articles about Pharma Growth Strategies LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharma Growth Strategies LLC Companies in our database. You can also find out about relevant Pharma Growth Strategies LLC Drugs and Medications on this site too.

Quick Search


Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record